Mavenclad: payments to doctors
Payments that named Mavenclad as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $31.3M
- Providers
- 7,338
- Transactions
- 75,212
- Average per transaction
- $416
The per-transaction average — $416 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,338 providers the average total is $4,259, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| EMD Serono, Inc. | $30,955,795 | 99.1% |
| Merck Kgaa | $238,386 | 0.8% |
| Ares Trading SA | $57,087 | 0.2% |